BioTech/Drugs - Newark, CA, US
InCarda Therapeutics is an early-stage drug delivery company pioneering a novel approach of treating cardiovascular diseases and conditions by the inhalation route. The lead product under development is an inhaled therapy to treat a common atrial arrhythmia, paroxysmal atrial fibrillation (PAF).
Outlook
Apache
WordPress.org
AWeber
Microsoft Office 365
Google Cloud Hosting